Molecular physiology and pathophysiology of bilirubin handling by the blood, liver, intestine, and brain in the newborn

TWR Hansen, RJ Wong… - Physiological …, 2020‏ - journals.physiology.org
Bilirubin is the end product of heme catabolism formed during a process that involves
oxidation-reduction reactions and conserves iron body stores. Unconjugated …

A novel perspective on the biology of bilirubin in health and disease

S Gazzin, L Vitek, J Watchko, SM Shapiro… - Trends in molecular …, 2016‏ - cell.com
Unconjugated bilirubin (UCB) is known to be one of the most potent endogenous antioxidant
substances. While hyperbilirubinemia has long been recognized as an ominous sign of liver …

Guidelines on the management of abnormal liver blood tests

PN Newsome, R Cramb, SM Davison, JF Dillon… - Gut, 2018‏ - gut.bmj.com
These updated guidelines on the management of abnormal liver blood tests have been
commissioned by the Clinical Services and Standards Committee (CSSC) of the British …

Bilirubin nanoparticles as a nanomedicine for anti‐inflammation therapy

Y Lee, H Kim, S Kang, J Lee, J Park… - Angewandte Chemie …, 2016‏ - Wiley Online Library
Despite the high potency of bilirubin as an endogenous anti‐inflammatory compound, its
clinical translation has been hampered because of its insolubility in water. Bilirubin‐based …

Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases

KH Wagner, M Wallner, C Mölzer, S Gazzin… - Clinical …, 2015‏ - portlandpress.com
Bilirubin, the principal tetrapyrrole, bile pigment and catabolite of haem, is an emerging
biomarker of disease resistance, which may be related to several recently documented …

Oxidative theory of atherosclerosis and antioxidants

R Salvayre, A Negre-Salvayre, C Camaré - Biochimie, 2016‏ - Elsevier
Atherosclerosis is a multifactorial process that begins early in infancy and affects all the
humans. Early steps of atherogenesis and the evolution towards complex atherosclerotic …

Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases

Z Chen, CT Vong, C Gao, S Chen, X Wu… - Molecular …, 2020‏ - ACS Publications
Reactive oxygen species (ROS) are chemically reactive species that are produced in
cellular aerobic metabolism. They mainly include superoxide anion, hydrogen peroxide …

Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin

A Nocentini, A Bonardi, S Pratesi… - Journal of Enzyme …, 2022‏ - Taylor & Francis
Bilirubin (BR) is the final product of haem catabolism. Disruptions along BR
metabolic/transport pathways resulting from inherited disorders can increase plasma BR …

[PDF][PDF] Bilirubin and atherosclerotic diseases

L Vitek - Physiological research, 2017‏ - biomed.cas.cz
Bilirubin is the final product of heme catabolism in the systemic circulation. For decades,
increased serum/plasma bilirubin levels were considered an ominous sign of an underlying …

Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis

S **e, S Wei, X Ma, R Wang, T He, Z Zhang… - Frontiers in …, 2023‏ - frontiersin.org
Hereditary cholestatic liver disease caused by a class of autosomal gene mutations results
in jaundice, which involves the abnormality of the synthesis, secretion, and other disorders …